eltrombopag

Generic: eltrombopag olamine

Labeler: camber pharmaceuticals, inc.
NDC Directory HUMAN PRESCRIPTION DRUG ANDA Inactive Finished

Drug Facts

Product Profile

Brand Name eltrombopag
Generic Name eltrombopag olamine
Labeler camber pharmaceuticals, inc.
Dosage Form POWDER, FOR SUSPENSION
Routes
ORAL
Active Ingredients

eltrombopag olamine 12.5 mg/1

Manufacturer
Camber Pharmaceuticals, Inc.

Identifiers & Regulatory

Product NDC 31722-300
Product ID 31722-300_315730ec-c40c-af1a-e063-6294a90a010f
Product Type HUMAN PRESCRIPTION DRUG
Marketing Category ANDA
Application Number ANDA216620
Listing Expiration 2026-12-31
Marketing Start 2025-05-13

Pharmacologic Class

Classes
breast cancer resistance protein inhibitors [moa] increased megakaryocyte maturation [pe] increased platelet production [pe] organic anion transporting polypeptide 1b1 inhibitors [moa] thrombopoietin receptor agonist [epc] thrombopoietin receptor agonists [moa] ugt1a1 inhibitors [moa] ugt1a3 inhibitors [moa] ugt1a4 inhibitors [moa] ugt1a6 inhibitors [moa] ugt1a9 inhibitors [moa] ugt2b15 inhibitors [moa] ugt2b7 inhibitors [moa]

Normalized Code Variants

Searchable formats for this product NDC code

Digits Only 31722300
Hyphenated Format 31722-300

Supplemental Identifiers

RxCUI
1859498 2058980
UPC
0331722301251 0331722300124
UNII
4U07F515LG

Packaging Origin

Original Packager
true

Resolved Product View

Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.

Resolved Identity

Brand Name eltrombopag (source: ndc)
Generic Name eltrombopag olamine (source: ndc)
Application Number ANDA216620 (source: ndc)
Routes
ORAL
source: ndc

Resolved Composition

Strengths
  • 12.5 mg/1
source: ndc
Packaging
  • 1 CARTON in 1 KIT (31722-300-32) / 30 PACKET in 1 CARTON (31722-300-31) / 1 POWDER, FOR SUSPENSION in 1 PACKET (31722-300-12)
source: ndc

Packages (1)

31722-300-32 1 CARTON in 1 KIT (31722-300-32) / 30 PACKET in 1 CARTON (31722-300-31) / 1 POWDER, FOR SUSPENSION in 1 PACKET (31722-300-12)

Ingredients (1)

eltrombopag olamine (12.5 mg/1)

Linked Drug Pages (1)

Eltrombopag ndc-match (0.9)

Raw FDA Data

View complete raw FDA NDC JSON payload 
{"route": ["ORAL"], "spl_id": "315730ec-c40c-af1a-e063-6294a90a010f", "openfda": {"upc": ["0331722301251", "0331722300124"], "unii": ["4U07F515LG"], "rxcui": ["1859498", "2058980"], "spl_set_id": ["8f6499f0-4774-4f1e-8ab5-145c1fe64401"], "manufacturer_name": ["Camber Pharmaceuticals, Inc."], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "1 CARTON in 1 KIT (31722-300-32)  / 30 PACKET in 1 CARTON (31722-300-31)  / 1 POWDER, FOR SUSPENSION in 1 PACKET (31722-300-12)", "package_ndc": "31722-300-32", "marketing_start_date": "20250513"}], "brand_name": "Eltrombopag", "product_id": "31722-300_315730ec-c40c-af1a-e063-6294a90a010f", "dosage_form": "POWDER, FOR SUSPENSION", "pharm_class": ["Breast Cancer Resistance Protein Inhibitors [MoA]", "Increased Megakaryocyte Maturation [PE]", "Increased Platelet Production [PE]", "Organic Anion Transporting Polypeptide 1B1 Inhibitors [MoA]", "Thrombopoietin Receptor Agonist [EPC]", "Thrombopoietin Receptor Agonists [MoA]", "UGT1A1 Inhibitors [MoA]", "UGT1A3 Inhibitors [MoA]", "UGT1A4 Inhibitors [MoA]", "UGT1A6 Inhibitors [MoA]", "UGT1A9 Inhibitors [MoA]", "UGT2B15 Inhibitors [MoA]", "UGT2B7 Inhibitors [MoA]"], "product_ndc": "31722-300", "generic_name": "Eltrombopag olamine", "labeler_name": "Camber Pharmaceuticals, Inc.", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Eltrombopag", "active_ingredients": [{"name": "ELTROMBOPAG OLAMINE", "strength": "12.5 mg/1"}], "application_number": "ANDA216620", "marketing_category": "ANDA", "marketing_start_date": "20250513", "listing_expiration_date": "20261231"}